Short Communication - (2025) Volume 9, Issue 2
Received: 01-Apr-2025, Manuscript No. jid-26-186465;
Editor assigned: 03-Apr-2025, Pre QC No. P-186465;
Reviewed: 17-Apr-2025, QC No. Q-186465;
Revised: 22-Apr-2025, Manuscript No. R-186465;
Published:
29-Apr-2025
, DOI: 10.37421/2684-4559.2025.9.323
Citation: Al-Fulan, Aisha. "Colistin Resistance: A Growing Threat in Klebsiella." Clin Infect Dis 13 (2025):323.
Copyright: © 2025 Al-Fulan A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The alarming rise of plasmid-mediated colistin resistance, particularly the mcr genes, within clinical Klebsiella strains presents a significant global health challenge. This phenomenon is driven by complex genetic mechanisms and has seen rapid epidemiological spread, posing serious implications for patient care and public health initiatives. Urgent surveillance and control strategies are therefore essential to mitigate its impact. [1]
The prevalence and molecular characterization of mcr-1, mcr-2, and mcr-3 genes within Enterobacteriaceae isolated from hospitalized patients are a growing concern. The conjugation of these resistance genes to mobile genetic elements further facilitates their rapid dissemination across diverse bacterial species, complicating treatment options. [2] The clinical ramifications of colistin-resistant Klebsiella pneumoniae infections are profound, with studies indicating higher mortality rates and prolonged hospital stays when compared to infections with susceptible strains. This underscores the critical need for the development of effective therapeutic alternatives and stringent infection control measures within healthcare settings. [3] A comprehensive review of the global epidemiology of mcr-mediated colistin resistance highlights its concerning spread from livestock to human populations. Understanding the molecular mechanisms of mcr gene acquisition and dissemination, including horizontal gene transfer via plasmids and transposons, is crucial for effective intervention. [4] The intricate role of the gut microbiome in the emergence and dissemination of colistin resistance is an area of ongoing investigation. It is suggested that antibiotic pressure can significantly alter gut microbial composition, creating an environment that favors the selection and carriage of resistant bacteria, including Klebsiella species. [5] Detailed investigation into the genetic environment surrounding the mcr-1 gene in Klebsiella isolates has identified common mobile genetic elements such as insertion sequences and plasmids. These elements are instrumental in contributing to the stability and transferability of the resistance gene, offering insights into the evolutionary dynamics of resistance. [6] Advancements in novel diagnostic methods for the rapid detection of plasmid-mediated colistin resistance in clinical settings are crucial. Early and accurate identification is paramount for enabling timely intervention and ensuring effective patient management strategies. [7] The efficacy of various antibiotic combinations against extensively drug-resistant Klebsiella pneumoniae strains carrying mcr genes is being evaluated. Identifying potential therapeutic strategies to overcome colistin resistance offers a glimmer of hope for treating increasingly challenging infections. [8] The adoption of a One Health approach is vital in combating the pervasive threat of antimicrobial resistance. This approach emphasizes the interconnectedness of human, animal, and environmental health in the context of colistin resistance, advocating for a coordinated global effort. [9] Analyzing the molecular mechanisms of horizontal gene transfer of mcr genes in Klebsiella strains, with a specific focus on the roles of plasmids and bacteriophages, is essential. A thorough understanding of these mechanisms is vital for developing effective strategies aimed at limiting the spread of resistance. [10]The investigation into the alarming rise of plasmid-mediated colistin resistance, specifically the mcr genes, within clinical Klebsiella strains reveals critical genetic mechanisms and epidemiological patterns. The study highlights the significant implications for patient care and public health, emphasizing the urgent need for robust surveillance and control strategies to combat this growing threat. [1]
A detailed examination of the prevalence and molecular characterization of mcr-1, mcr-2, and mcr-3 genes in Enterobacteriaceae isolated from hospitalized patients has been conducted. The research further elucidates the conjugation of these resistance genes to mobile genetic elements, which significantly facilitates their rapid dissemination across different bacterial species, posing a considerable challenge to clinical management. [2] This research critically assesses the clinical impact of colistin-resistant Klebsiella pneumoniae infections, reporting notably higher mortality rates and prolonged hospital stays compared to infections caused by susceptible strains. The findings strongly emphasize the urgent necessity for the development of effective therapeutic alternatives and the implementation of stringent infection control measures within healthcare environments. [3] A comprehensive review has provided an in-depth understanding of the global epidemiology of mcr-mediated colistin resistance, illustrating its concerning trajectory of spread from livestock to human populations. The study also delves into the molecular mechanisms underlying mcr gene acquisition and dissemination, particularly focusing on horizontal gene transfer mediated by plasmids and transposons. [4] This article explores the multifaceted role of the gut microbiome in the complex processes of emergence and dissemination of colistin resistance. It posits that sustained antibiotic pressure can alter the composition of the gut microbial community, thereby favoring the selection and carriage of resistant bacteria, including critical Klebsiella species. [5] The study has meticulously investigated the genetic landscape surrounding the mcr-1 gene within Klebsiella isolates. This has led to the identification of common mobile genetic elements, such as insertion sequences and plasmids, which are pivotal in enhancing its stability and transferability, thereby providing crucial insights into the evolutionary dynamics of antimicrobial resistance. [6] This research underscores the successful development and practical application of novel diagnostic methodologies designed for the rapid detection of plasmid-mediated colistin resistance in various clinical settings. The critical importance of early identification cannot be overstated, as it is directly linked to timely intervention and more effective patient management protocols. [7] The study evaluates the effectiveness of diverse antibiotic combinations when employed against extensively drug-resistant Klebsiella pneumoniae strains harboring mcr genes. The outcomes of this evaluation are crucial for identifying potential therapeutic strategies that can overcome colistin resistance, offering renewed hope for managing difficult-to-treat infections. [8] This article advocates for the adoption of a comprehensive One Health approach as a cornerstone in the global effort to combat antimicrobial resistance. It highlights the intrinsic interconnectedness of human, animal, and environmental health in the context of colistin resistance, calling for a unified and coordinated global response to address this pressing public health threat. [9] The study undertakes a detailed analysis of the molecular mechanisms governing the horizontal gene transfer of mcr genes within Klebsiella strains, with a particular emphasis on the significant roles played by plasmids and bacteriophages. A profound understanding of these mechanisms is considered vital for the development of targeted strategies aimed at effectively limiting the further spread of resistance. [10]This collection of research highlights the escalating threat of plasmid-mediated colistin resistance, primarily driven by mcr genes in clinical Klebsiella strains. Studies detail the genetic mechanisms, rapid spread through mobile genetic elements like plasmids and transposons, and the severe clinical consequences, including increased mortality. The research also explores the role of the gut microbiome, the development of rapid diagnostic tools, and the evaluation of antibiotic combinations. A One Health approach and understanding horizontal gene transfer are emphasized as crucial for combating this resistance. The findings underscore the urgent need for enhanced surveillance, effective control strategies, and the development of novel therapeutic alternatives to address this significant public health challenge.
Clinical Infectious Diseases: Open Access received 1149 citations as per Google Scholar report
